Wyeth Pharmaceuticals Inc.

Overview

Wyeth Pharmaceuticals Inc. is a subsidiary of Pfizer Inc., a leading global pharmaceutical company. Wyeth is renowned for its contributions to the development and manufacturing of innovative health solutions across various therapeutic areas, offering a diverse portfolio of drugs and vaccines.

Therapeutic areas

API / Drug Master Files

Wyeth Pharmaceuticals Inc. holds 0 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• BONE MORPHOGENETIC PROTEIN-2 (HUMAN, RECOMBINANT, CHO CELLS, WYETH)Inactive2002-09-06
• DEMECLOCYCLINE HYDROCHLORIDEInactive1998-09-01
• FACILITIES AND OPERATING PROCEDURES IN MUENSTER, WEST GERMANYInactive1990-01-31

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Wyeth Pharmaceuticals Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.